Alzheimer’s disease & dementia

Everyone knew my father. Sadly, he did not remember me.

Denis Richard

Watching Henri fade away was an extremely painful experience for Denis Richard and his extended family, as well as for the millions of Canadians who lost a loved one to Alzheimer’s disease or dementia.

Our mission is simple. Discover answers, find solutions, identify better prevention strategies, and ultimately eliminate the suffering experienced by those afflicted with Alzheimer’s disease and their families. Our world class team is leading multiple research projects dedicated to understanding the causes of Alzheimer’s and developing tangible prevention strategies and treatments.


Discover Denis’s story

Henri Richard, Denis’s father, died of Alzheimer’s disease. Supporting research on mental illness at the Douglas helps build hope for all those who suffer from neurodegenerative disorders.

A global approach

The Douglas is at the forefront of research, prevention and treatment of Alzheimer’s disease as well as dementia. Our researchers made many important clinical discoveries that helped to build hope for our patients.



Patient care


Total of Canadians currently affected by a neurocognitive disorder (i.e. Alzheimer’s disease, dementia).

Global percentage of people suffering from Alzheimer’s disease among neurocognitive disorder cases in Canada.

Number of people affected by Alzheimer’s Disease globally according to the most recent data available.

The Centre


The Douglas Institute’s integrated approach makes it possible to identify early markers of Alzheimer’s disease and dementia. The STOP-AD Centre studies Alzheimer’s disease in its pre-symptomatic stages and transfers our knowledge in basic and clinical sciences with multiple experts.

Want to learn more ?

Want to learn more about mental health research at the Douglas?

Visit the Douglas Research Centre’s website.

Want to learn more about the services offered at the Douglas?

Visit the Douglas Mental Health University Institute website.